EUVIMEDEUVIMED entdecken
Crossref

Longitudinal nationwide analysis of uveal melanoma in the United States 1995–2018

Ahmad Samir Alfaar, Mohamed H Abdel-Rahman, Moataz Hamed Osman

International Journal of Clinical Oncology · 2025

DOI: 10.1007/s10147-025-02870-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Ahmad Samir Alfaar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, University Hospital, Ulm University, Ulm, Germany. ahmad@alfaar.de. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults, yet comprehensive nationwide epidemiologic data remain limited. This study aimed to provide an updated analysis of UM incidence, survival, and disparities in the United States (US) using near-complete population coverage. METHODS: We analyzed data from the North American Association of Central Cancer Registries (NAACCR) and US Cancer Statistics (USCS) program between 1995 and 2018, covering 98-100% of the US population. Age-adjusted incidence rates (AAIRs) and relative survival were calculated using SEER*Stat and Joinpoint regression. RESULTS: A total of 37,917 UM cases were identified, with an overall AAIR of 5.54 per million (95% CI: 5.48-5.59), showing a stable but slightly increasing trend (AAPC = 0.06). Incidence was highest in non-Hispanic whites (6.87 ppm), men (6.25 ppm), and those aged 75-79 years. Geographic variation was notable, with peak incidence in Oregon and Iowa. Most tumors (81.3%) were localized at diagnosis, and 27.4% of patients had another primary malignancy. 5- and 10-year relative survival rates were 83.3% and 73.9%, respectively, with worse outcomes in metastatic disease. A shift toward radiotherapy, especially brachytherapy, was observed, although survival gains remained limited. CONCLUSIONS: This nationwide study refines US UM incidence estimates and highlights persistent disparities by sex, race, age, and geography. The high prevalence of secondary malignancies underscores the need for genetic counseling and extended surveillance. Despite advances in imaging, local therapies (e.g., brachytherapy, proton therapy), and emerging systemic approaches including immunotherapy, survival improvements in advanced UM remain limited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaUveal NeoplasmsHumansUnited StatesUveal MelanomaMaleFemaleAgedMiddle AgedIncidenceAdultSEER ProgramAged, 80 and overLongitudinal StudiesYoung AdultSurvival RateAdolescentRegistries

Stichwörter der Autor:innen

Ethnic disparitiesIncidenceOcular oncologySurvivalUveal melanoma

Autor:innen und Institutionen

  • Ophthalmology Department, University Hospital, Ulm University, Ulm, Germany. ahmad@alfaar.de.
  • Experimental Ophthalmology, Department of Ophthalmology, Charité - Universitätsmedizin Berlin, Freie Universität, the Berlin Institute of Health, Humboldt-University, 13353, Berlin, Germany. ahmad@alfaar.de.
  • Department of Ophthalmology and Visual Science, The Ohio State University, Columbus, OH, USA.
  • Division of Human Genetics, Department of Internal Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Ophthalmology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

Zitieren

APA

Alfaar, A. S., Abdel-Rahman, M. H., & Osman, M. H. (2025). Longitudinal nationwide analysis of uveal melanoma in the United States 1995–2018. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02870-7

Vancouver

Alfaar AS, Abdel-Rahman MH, Osman MH. Longitudinal nationwide analysis of uveal melanoma in the United States 1995–2018. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-025-02870-7

BibTeX
@article{Alfaar2025,
  author = {Alfaar, Ahmad Samir and Abdel-Rahman, Mohamed H and Osman, Moataz Hamed},
  title = {Longitudinal nationwide analysis of uveal melanoma in the United States 1995–2018},
  journal = {International Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1007/s10147-025-02870-7}
}
Kostenlos starten →